
American Express (AXP) is strategically adapting to the Buy Now Pay Later (BNPL) trend by integrating its 'Plan It' feature, allowing cardholders to convert purchases into monthly installments within its existing ecosystem. This proactive approach has contributed to a 7% year-over-year network volume growth in Q2 2025 and 98% spend retention, with its closed-loop model poised to generate increased interest income from BNPL. While AXP's stock is down 2.9% year-to-date against an industry rise, its forward P/E of 18.4x is below the industry average, and analysts project a 14.3% earnings jump for 2025, indicating a strong position to leverage, rather than be disrupted by, the evolving payments landscape.
American Express is strategically adapting to the Buy Now Pay Later (BNPL) trend not by launching a standalone competitor, but by integrating BNPL functionality directly into its core card ecosystem via the 'Plan It' feature. This approach leverages its established brand trust and rewards programs, contributing to an exceptionally high 98% spend retention rate. The strategy is yielding tangible results, with network volume growing 7% year-over-year in the second quarter of 2025, comparable to PayPal's 6% payment volume growth in the same period, though lagging the hyper-growth of pure-play BNPL firms like Affirm. Despite this operational strength and a consensus earnings forecast projecting a 14.3% jump in 2025, AXP's stock has underperformed, declining 2.9% year-to-date against the industry's 3.8% gain. This market performance disconnect creates a compelling valuation case, as the stock trades at a forward price-to-earnings ratio of 18.4x, a discount to the industry average of 20.6x. The company's closed-loop business model is also well-positioned to directly capture increased interest income as installment payments become more prevalent.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
moderately positive
Sentiment Score
0.50
Ticker Sentiment